Literature DB >> 31712955

Effect of the severity of acute graft-versus-host disease on physical function after allogeneic hematopoietic stem cell transplantation.

Ryota Hamada1, Tadakazu Kondo2, Masanobu Murao1, Jyunsuke Miyasaka1, Michiko Yoshida1, Manabu Nankaku1, Junya Kanda3, Akifumi Takaori-Kondo3, Ryosuke Ikeguchi1, Shuichi Matsuda1.   

Abstract

PURPOSE: The purpose of this study was to retrospectively investigate the effect of the severity of acute graft-versus-host disease (GVHD) on physical function after allogeneic hematopoietic stem cell transplantation (allo-HSCT).
METHODS: 76 patients were included as subjects of this study. Severity of acute GVHD was classified according to the method defined by Grucksberg. To evaluate physical function, the knee extensor strength and six-minute walk distance (6MWD) were performed.
RESULTS: Among these patients, 54% developed acute GVHD; of these, 32%, 54%, and 15% of patients had grade I, grade II, and grades III-IV GVHD, respectively. In the grade I-II groups, mild acute GVHD following allo-HSCT resulted in a gradual decline in physical function, which improved at discharge. However, in cases of severe acute GVHD, physical function deteriorated, implementation of rehabilitation became difficult, and the decline in physical function persisted even at discharge.
CONCLUSION: These results indicate that severe acute GVHD negatively affects physical function leading to longer hospital days because of inadequate rehabilitation interventions.

Entities:  

Keywords:  Acute graft-versus-host disease (GVHD); Allogeneic hematopoietic stem cell transplantation (allo-HSCT); Knee extensor strength; Six-minute walk distance (6MWD)

Year:  2019        PMID: 31712955     DOI: 10.1007/s00520-019-05124-1

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  8 in total

1.  Muscle oxygen extraction and lung function are related to exercise tolerance after allogeneic hematopoietic stem cell transplantation.

Authors:  Tatsushi Wakasugi; Shinichiro Morishita; Katsuji Kaida; Kazuhiro Ikegame; Yuki Uchiyama; Kazuhisa Domen
Journal:  Support Care Cancer       Date:  2021-03-30       Impact factor: 3.603

Review 2.  What else do I need to worry about when treating graft-versus-host disease?

Authors:  Areej El-Jawahri
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

3.  Evaluation of indices for predicting recovery of exercise tolerance in patients surviving allogenic hematopoietic stem cell transplantation.

Authors:  Ryota Hamada; Tadakazu Kondo; Kazuhiro Harada; Masanobu Murao; Junsuke Miyasaka; Michiko Yoshida; Honami Yonezawa; Manabu Nankaku; Yasuyuki Arai; Junya Kanda; Akifumi Takaori-Kondo; Ryosuke Ikeguchi; Shuichi Matsuda
Journal:  Support Care Cancer       Date:  2022-01-22       Impact factor: 3.603

4.  Reliability and validity of ultrasound to measure of muscle mass following allogeneic hematopoietic stem cell transplantation.

Authors:  Nao Hashida; Yuma Tada; Masayuki Suzuki; Kumiko Ito; Yuji Kato; Hironari Tamiya; Jun Ishikawa
Journal:  Sci Rep       Date:  2022-01-27       Impact factor: 4.379

Review 5.  Burden and Needs of Patients with Severe GvHD from the Supportive and Palliative Care Perspective-A Literature Review.

Authors:  Freya Wenzel; Anne Pralong; Udo Holtick; Christoph Scheid; Marco Herling; Steffen T Simon
Journal:  Cancers (Basel)       Date:  2021-05-30       Impact factor: 6.639

6.  Pre-transplant Rehabilitation to Decrease the Post-transplant Length of Stay for Hematological Malignancy Patients Undergoing Allo-HSCT.

Authors:  Ryutaro Matsugaki; Makoto Ohtani; Yuko Mine; Satoru Saeki; Kiyohide Fushimi; Shinya Matsuda
Journal:  Prog Rehabil Med       Date:  2021-04-28

7.  Screening supportive care needs, compliance with exercise program, quality of life, and anxiety level during the COVID-19 pandemic in individuals treated with hematopoietic stem cell transplantation.

Authors:  Vesile Yildiz Kabak; Songul Atasavun Uysal; Tulin Duger
Journal:  Support Care Cancer       Date:  2021-01-06       Impact factor: 3.359

8.  Feasibility of early-commencing group-based exercise in allogeneic bone marrow transplantation: the BOOST study.

Authors:  Shaza Abo; David Ritchie; Linda Denehy; Yvonne Panek-Hudson; Louis Irving; Catherine L Granger
Journal:  Bone Marrow Transplant       Date:  2021-07-16       Impact factor: 5.174

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.